BioPharmaceutical glossaries & taxonomies newest definitions

You are here > Biopharmaceutical Glossary Homepage/Search Index > Newest biopharmaceutical definitions

Newest biopharmaceutical definitions
Evolving Terminology for Emerging Technologies
Comments? Questions? Revisions? Mary Chitty mchitty@healthtech.com
Last revised September 26, 2008
View a Printer-Friendly Version of this Web Page!

New Page 1

Please register for CHI's Genomics Glossaries & Taxonomies website. This sign-in box with then disappear from each page, if you accept cookies. Use of this site will continue to be free, but better demographic data on who is accessing this material helps us to justify the expense of maintaining this resource. Registration policy has details. Registered users of the Genomics Glossaries & Taxonomies will automatically be signed up for CHI's complimentary email monthly newsletter, GenomeLink, unless you choose to opt out of receiving it.
	Mr. Ms. Mrs. Dr. Prof.
First:		Last:
Title:		Dept.:
Company:
Address:
City:
State:	Zip:
Country:
Email:
Opt-out of Email	YES NO
Telephone:
	Would you like to receive CHI event updates via fax? Yes No
Fax:

21st century Drug discovery & development Map Informatics map Technologies map Biology & chemistry map Finding guide to terms in these glossaries Site Map
** newest of the new definitions

accelerator mass spectrometry: Mass spectrometry

adaptive clinical trials: Drug approvals and clinical trials

Bayesian clinical trials: Drug approvals and clinical trials

biological chemistry: Chemistry (& biology)

biomathematics Algorithms

biomedical polymers: Biomaterials

biomolecular screening: Assays & screening

chaperome: -Omes & -omics

cellular dielectric spectroscopy CDS:

combination therapies: Drug Discovery & Development

comparative systems biology: Genomic Manipulation & Disruption

computational physiology: In Silico & Molecular Modeling

computational sensing: Labels Signaling & detection

Copy Number Polymorphisms CNPs: SNPs and Genetic Variations

developability: Drug discovery & development

diffusion tensor imaging: Molecular imaging

disproportionate drug metabolite: Drug safety, Pharmacovigilance & toxicology

drug metabolism: Pharmacogenomics

e-health: http://en.wikipedia.org/wiki/EHealth

evidence based toxicology: Drug safety, Pharmacovigilance & toxicology

exploratory IND: Drug approvals

expressomics: -Omes & -omics

follow-on drug: Drug discovery & development

fragment based drug discovery Assays and screening

genetic susceptibility: Molecular diagnostics -- genetic & genomic testing

GIS Geographic Information Systems: Molecular Medicine and Diagnostics

GSK: GlaxoSmithKline

green chemistry: Chemistry & biology

inflammasome: -Omes & -omics

integrative and organ systems pharmacology: Pharmacogenomics

** in vitro adventitious assays: Assays & screening

in vitro diagnostic multivariate index assays IVDMIAs: Genetic & genomic testing

label free detection: Labels Signaling & detection

lead hopping: Assays

mass spectrometry" IUPAC Mass Spectrometry Standard definitions of terms relating to mass spectrometry Provisional recommendations, 2006 http://www.iupac.org/reports/provisional/abstract06/murray_prs.pdf

materials chemistry: Chemistry & biology

medical resequencing: Sequencing

mesoscopic biology: Expression genes & proteins

metabolite: Drug safety, Pharmacovigilance & toxicology

microdosing Pharmacogenomics

mitochondriomics: -Omes & -omics

molecular biosensors: Labels Signaling & detection

molecular crowding: Biomolecules

molecular electronics: Nanoscience & miniaturization

molecular events: Cancer genomics

molecular pharmacology Pharmacogenomics

nanolabels: Labels Signaling & detection

nanomedicine: Nanoscience & miniaturization

nanotechnology in the clinical laboratory setting: Molecular Medicine

natural competence: DNA

next generation sequencing: Sequencing

-Omes & -omics: Lots of new terms including alleome, chromatinomics, chromosonics, cryobionomics,
embryogenomics, epitomics, fragonomics, lectinomics, mitogenomics, Nobonomics, paleogenomics, RNome, RNomics, separomics, strainomics, transgenomics

pharmacokinetics pharmacodynamics: Pharmacogenomics

pharmacologically active metabolite: Drug safety, Pharmacovigilance & toxicology

Phase zero, Phase O: Drug approvals

pipeline problem: Drug discovery

post-genomic chemistry: Chemistry & biology

predictive ADME: Drug safety & pharmacovigilance

predictive toxicology: Drug safety, toxicology & pharmacovigilance

process chemistry: Chemistry & biology

Proteomic Standards Initiative: Proteomics

resourceome: -Omes & -Omics

ridiculome: -Omes & -Omics

safety pharmacology: Drug Safety & Pharmacovigilance